Search Results - "Kitzmueller, M"

Multiple dose pharmacokinetics of erlotinib when combined with gastric acid reducing agents: A comparison with a physiologically based pharmacokinetic model by Hrgovcic, A. Sahmanovic, Gruber, A., Dittrich, C., Kitzmueller, M., Buchner, P., Baroian, N. Kirchbaumer, Czejka, M.

Get full text

P-139Monitoring of erlotinib plasma concentrations after long time administration of 100 mg in advanced pancreatic cancer patients by Sahmanovic, A, Buchner, P, Lichtneckert, M, Dittrich, C, Farkouh, A, Gruber, A, Baroian, N, Kitzmueller, M, Czejka, M

Get full text

2098 Assessment of pharmacokinetic (PK) interaction between cetuximab (CTX) and capecitabine (CCB) or oxaliplatin (OX) in metastatic colorectal cancer (mCRC) patients (pts) (AGMT_CAPECET_PK) by Schreiber, V, Kitzmueller, M, Buchner, P, Weissenboeck, N, Lichtneckert, M, Greil, R, Geiler, H, Czejka, M, Dittrich, C

Get full text

P-168Multiple dose pharmacokinetics of erlotinib when combined with gastric acid reducing agents: A comparison with a physiologically based pharmacokinetic model by Hrgovcic, A Sahmanovic, Gruber, A, Dittrich, C, Kitzmueller, M, Buchner, P, Baroian, N Kirchbaumer, Czejka, M

Get full text

P-139 Monitoring of erlotinib plasma concentrations after long time administration of 100 mg in advanced pancreatic cancer patients by Sahmanovic, A., Buchner, P., Lichtneckert, M., Dittrich, C., Farkouh, A., Gruber, A., Baroian, N., Kitzmueller, M., Czejka, M.

Get full text